Monday of this week, in a Texas Federal court, SolarWinds sought to have dismissed a shareholder suit alleging that the company tricked investors by not disclosing in advance company vulnerability to cyber attacks of its software product Orion. Plaintiffs claimed … Continue reading
Stephen Honig
The problem is: it often is both. Remarks yesterday by SEC chair Gensler called for Congress to pass legislation making clearer the regulatory powers of the SEC over certain forms of crypto-currency; to date, the SEC has regulated crypto by … Continue reading
A recent article in Law 360 (a service to attorneys) collected a covey of interesting factoids relating to a major hamburger vendor’s legal tangle relating to discrimination and harassment. Seems Mickey D has been accused of sins in these areas, … Continue reading
By now it is common knowledge that calculating commercial interest rates using LIBOR is no longer possible; the disclosure of LIBOR manipulations tolled its death knell. The influential New York Federal Reserve Bank has proposed a replacement metric (“Term SOFR”), … Continue reading
After a wet and tumultuous July, I have gathered my wits again and have begun posting to this blog site on legal matters. However, on occasion I have written about other subjects when anomalies of life have struck me as– … Continue reading
While most businesses acknowledge the potential impact of climate on their operations, and many people see first-hand the potential for disruption due to climate change, there is a dispute as to the role of the SEC in disclosing climate factors … Continue reading
In my May 5 post, I predicted that the SEC’s animosity to SPACs would not fade away. It was easy prophesy and of course it has come to pass. In an announcement issued yesterday, the SEC’s Office of Investor Education … Continue reading
Everyone knows that insider trading is illegal and can create liability for the person who gives the “tip” and the person who trades based on the “tip.” So why did the US House of Representatives enact the Insider Trading Prohibition … Continue reading
A week ago, panelists at an ambitious program mounted by the Boston Bar Association took a broad look at major trends in life science deals and risks. Some interesting highlights follow. Did COVID hurt or help life science dealmaking? Both; … Continue reading
We all recall the game Whack-a-Mole. That is what is happening to the SPAC marketplace. Aside from questions in the marketplace as to the advisability of using this model as an investment vehicle or a method of going public, seems … Continue reading